GLP1R and diabetes mellitus: A 26-weeks randomized controlled trial in the Netherlands found that GLP1-RA treatment in 26 patients significantly improved the quality of life measured by the Problem Areas in Diabetes Scale (PAID) questionnaire, compared to 24 patients using standard treatment (de Wit et al., 2014).